Cullen/Frost Bankers’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.9M | Sell |
41,677
-480
| -1% | -$230K | 0.21% | 97 |
|
|
2026
Q1 | $20.7M | Buy |
42,157
+3,842
| +10% | +$2.09M | 0.24% | 93 |
|
|
2025
Q4 | $22.2M | Buy |
38,315
+2,757
| +8% | +$1.56M | 0.24% | 88 |
|
|
2025
Q3 | $17.2M | Buy |
35,558
+2,769
| +8% | +$1.29M | 0.2% | 104 |
|
|
2025
Q2 | $13.3M | Buy |
32,789
+1,754
| +6% | +$733K | 0.17% | 130 |
|
|
2025
Q1 | $15.4M | Buy |
31,035
+486
| +2% | +$263K | 0.22% | 110 |
|
|
2024
Q4 | $15.9M | Buy |
30,549
+1,553
| +5% | +$854K | 0.22% | 108 |
|
|
2024
Q3 | $17.9M | Buy |
28,996
+1,165
| +4% | +$690K | 0.24% | 104 |
|
|
2024
Q2 | $15.4M | Buy |
27,831
+764
| +3% | +$438K | 0.22% | 105 |
|
|
2024
Q1 | $15.7M | Sell |
27,067
-933
| -3% | -$524K | 0.23% | 107 |
|
|
2023
Q4 | $14.9M | Buy |
28,000
+1,257
| +5% | +$608K | 0.23% | 105 |
|
|
2023
Q3 | $13.5M | Buy |
26,743
+476
| +2% | +$254K | 0.24% | 106 |
|
|
2023
Q2 | $13.7M | Buy |
26,267
+2,056
| +8% | +$1.11M | 0.23% | 110 |
|
|
2023
Q1 | $14M | Buy |
24,211
+1,769
| +8% | +$997K | 0.26% | 107 |
|
|
2022
Q4 | $12.4M | Buy |
22,442
+3,783
| +20% | +$2M | 0.24% | 116 |
|
|
2022
Q3 | $9.46M | Buy |
18,659
+173
| +0.9% | +$96.8K | 0.22% | 113 |
|
|
2022
Q2 | $10M | Sell |
18,486
-316
| -2% | -$174K | 0.23% | 112 |
|
|
2022
Q1 | $11.1M | Buy |
18,802
+50
| +0.3% | +$28.7K | 0.22% | 112 |
|
|
2021
Q4 | $12.5M | Sell |
18,752
-542
| -3% | -$338K | 0.24% | 99 |
|
|
2021
Q3 | $11M | Buy |
19,294
+9,988
| +107% | +$5.48M | 0.22% | 108 |
|
|
2021
Q2 | $4.7M | Sell |
9,306
-46
| -0.5% | -$21.7K | 0.09% | 192 |
|
|
2021
Q1 | $4.27M | Buy |
9,352
+255
| +3% | +$122K | 0.09% | 190 |
|
|
2020
Q4 | $4.24M | Sell |
9,097
-128
| -1% | -$60K | 0.1% | 176 |
|
|
2020
Q3 | $4.07M | Sell |
9,225
-715
| -7% | -$295K | 0.1% | 171 |
|
|
2020
Q2 | $3.6M | Buy |
9,940
+9,420
| +1,812% | +$3.16M | 0.1% | 181 |
|
|
2020
Q1 | $147K | Sell |
520
-72
| -12% | -$22.7K | 0.01% | 405 |
|
|
2019
Q4 | $192K | Buy |
592
+312
| +111% | +$94.6K | 0.01% | 423 |
|
|
2019
Q3 | $82K | Sell |
280
-105
| -27% | -$30.1K | ﹤0.01% | 501 |
|
|
2019
Q2 | $113K | Buy |
385
+151
| +65% | +$41.6K | ﹤0.01% | 459 |
|
|
2019
Q1 | $64K | Buy |
+234
| New | +$58.2K | ﹤0.01% | 533 |
|
|
2018
Q2 | – | Sell |
-1,044
| Closed | -$216K | – | 442 |
|
|
2018
Q1 | $216K | Sell |
1,044
-145
| -12% | -$30.4K | 0.01% | 402 |
|
|
2017
Q4 | $226K | Sell |
1,189
-139
| -10% | -$26.6K | 0.01% | 364 |
|
|
2017
Q3 | $251K | Sell |
1,328
-79
| -6% | -$14.3K | 0.01% | 342 |
|
|
2017
Q2 | $246K | Sell |
1,407
-52
| -4% | -$8.73K | 0.01% | 338 |
|
|
2017
Q1 | $224K | Sell |
1,459
-300
| -17% | -$45.9K | 0.01% | 352 |
|
|
2016
Q4 | $248K | Buy |
1,759
+427
| +32% | +$63K | 0.01% | 344 |
|
|
2016
Q3 | $212K | Buy |
+1,332
| New | +$205K | 0.01% | 359 |
|
|
2016
Q1 | – | Sell |
-1,483
| Closed | -$211K | – | 379 |
|
|
2015
Q4 | $211K | Buy |
+1,483
| New | +$198K | 0.01% | 359 |
|
|
2015
Q2 | – | Sell |
-1,914
| Closed | -$257K | – | 391 |
|
|
2015
Q1 | $257K | Buy |
+1,914
| New | +$247K | 0.01% | 359 |
|
Other funds holding TMO
Cullen/Frost Bankers's TMO Position: Q2 2026 in Review
Cullen/Frost Bankers reduced its Thermo Fisher Scientific (TMO) stake by 1.1% in Q2 2026, selling an estimated $230K and leaving 41,677 shares worth $20.9M. The position accounts for 0.21% of the portfolio, ranked #97.
Cullen/Frost Bankers first reported a position in TMO in Q1 2015 and has held it in 39 quarters since. The position peaked at $22.2M in Q4 2025. 1,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Cullen/Frost Bankers held 41,677 shares of Thermo Fisher Scientific worth $20.9M as of Q2 2026.
- Cullen/Frost Bankers sold 480 Thermo Fisher Scientific shares in Q2 2026, an estimated $230K.
- Thermo Fisher Scientific made up 0.21% of Cullen/Frost Bankers's portfolio in Q2 2026, its #97 holding.
- Cullen/Frost Bankers first reported a position in Thermo Fisher Scientific in Q1 2015 and has held it in 39 quarters since.
- Cullen/Frost Bankers's Thermo Fisher Scientific position peaked at $22.2M in Q4 2025.
- 1,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.